
What We’re Reading: Expanding Naloxone Access; US Childhood Vaccinations Drop; New COVID-19 Booster Reconsidered
Greater availability of naloxone spray, including over the counter, may reduce opioid overdoses; vaccination rates drop once again for US children; some experts question the necessity of the updated COVID-19 booster shot.
Naloxone Access Could Increase With Policy Shifts
In response to increasing rates of opioid overdoses, particularly fentanyl, federal policy is shifting to make the overdose reversal drug naloxone more accessible to the public, according to
US Childhood Vaccination Rates Dip Again
Vaccination rates during the 2021-2022 school year dipped once again for US kindergarten-age children against diseases such as polio, measles, and diphtheria, according to
Data Do Not Support COVID-19 Booster Shots for Most, Expert Says
New data suggest the new COVID-19 booster isn’t much more effective in generating neutralizing antibodies than the original vaccine, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.